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I ntroducti on
Endosomal sorting processes determine the fate of plasma membrane receptors that are either recycled or delivered to the lysosome for degradation. (Gruenberg and Stenmark, 2004; Hicke, 2001; Katzmann et al., 2002 ). An intricate network of protein interactions, which includes the sequential recruitment of ESCRT (Endosomal Sorting Complexes Required for Transport) complexes 0, I, II and III and associated molecules, regulates endosomal protein sorting, vesicle formation and budding (Saksena et al., 2007) (Hurley, 2008) (Lata et al., 2009 ). The accessory protein ALIX interacts with ESCRT-I Tsg101 (Mahul-Mellier et al., 2006; as well as with all ESCRT-III CHMP4 isoforms (Odorizzi et al., 2003) (Katoh et al., 2003) (Fisher et al., 2007) (McCullough et al., 2008) . ESCRT-III proteins polymerize on membranes (Babst et al., 2002) (Lin et al., 2005) by forming filamentous (Ghazi-Tabatabai et al., 2008) , circular (Hanson et al., 2008) and helical tubular structures (Lata et al., 2008b ) that act during membrane remodeling processes including membrane abscission (Lata et al., 2009 ). ESCRT-III proteins form inactive closed conformations in the cytosol and undergo polymerization and membrane targeting upon activation (Muziol et al., 2006) (Shim et al., 2007) (Lata et al., 2008a) (Lata et al., 2008b) . It is most likely that ALIX interacts only with an activated form of CHMP4 via a C-terminal CHMP4 binding motif (McCullough et al., 2008) . Thus ALIX function must be linked to the role of ESCRT-III in membrane remodeling processes. In fact, ALIX itself might directly control changes in membrane structures (Matsuo et al., 2004) (Falguieres et al., 2008) .
inserm-00405383, version 1 -25 Jan 2010 4 ALIX was originally thought to be a homologue of yeast Bro1 that functions in receptor down regulation (Odorizzi et al., 2003) (Kim et al., 2005) , but this role could not be confirmed (Cabezas et al., 2005) (Schmidt et al., 2004) (Doyotte et al., 2008) .
ALIX is recruited to the budding process of some enveloped viruses such as HIV-1 and equine infectious anemia virus (EIAV) (von Schwedler et al., 2003) (Martin-Serrano et al., 2003) . Although EIAV budding is strictly dependent on ALIX (Martin-Serrano et al., 2003) , the EIAV late domain can be replaced by ESCRT-I Vps28, which provides access to ESCRT-III (Tanzi et al., 2003 ) . In contrast, ALIX is not sufficient to support HIV-1 budding in the absence of the Tsg101/ESCRT-I function (Garrus et al., 2001 ) (MartinSerrano et al., 2001) . However, over-expression of ALIX or NEDD4 can rescue HIV-1 late domain mutants (Usami et al., 2007) (Usami et al., 2008) .
Both ALIX and ESCRT-III family members are recruited to the midbody during cytokinesis (Carlton and Martin-Serrano, 2007) (Morita et al., 2007) where ALIX competes with Tsg101 for CEP55 interaction (Lee et al., 2008) . Although CEP55 itself is not required for virus budding nor any endosome-related processes, virus budding and cytokinesis require ESCRT-III and VPS4 function.
ALIX is composed of three domains, an N-terminal Bro1-like domain (Kim et al., 2005) (Fisher et al., 2007) , which harbors the CHMP4B binding site (McCullough et al., 2008) , followed by the V-shaped middle domain composed of two three helical bundles that expose the retroviral late domain binding sites (Lee et al., 2007) (Fisher et al., 2007) (Zhai et al., 2008) ; the third domain is a proline rich domain (PRD) that serves as a platform for multiple interaction partners including ESCRT-I Tsg101 (von Schwedler et inserm-00405383, version 1 -25 Jan 2010 al., 2003) (Shibata et al., 2004) (Schmidt et al., 2004) (Chatellard-Causse et al., 2002) and CEP55 (Carlton and Martin-Serrano, 2007) (Morita et al., 2007) (Lee et al., 2008) . PRD harbors the Alg-2 binding site (Suzuki et al., 2008) , which links ALIX to apoptotic processes (Missotten et al., 1999) (Vito et al., 1999) (Trioulier et al., 2004) (Mahul-Mellier et al., 2006 )(Mahul-Mellier et al., 2008 . The scaffold function of ALIX is further underlined by its control of the actin cytoskeleton (Cabezas et al., 2005; Schmidt et al., 2003) (Pan et al., 2006) . Finally PRD regulates the function of ALIX by keeping it in an auto-inhibited state (Zhou et al., 2008b) (Zhou et al., 2008a ).
Here we show that ALIX dimerizes in vitro and in vivo via the V-domain, which helps to explain the dominant negative effect on HIV-1 budding observed for truncated ALIX constructs. We determine a main dimerization interface within the hinge region of the V-domain and present a low resolution model of dimeric ALIX based on SAXS analysis. Electron microscopy data indicate further that dimeric ALIX can bridge CHMP4 filaments. Such a scaffolding function may thus help to position ESCRT-III on membranes and allow recruitment of a variety of effectors via its PRD region.
Re sul ts
M ALLS and SAXS anal ysi s of ALI X. Both recombinant ALIX Bro1-V and ALIX V elute from gel filtration columns in two distinct peaks. Analytical size exclusion chromatography in combination with multi angle laser light scattering (MALLS) revealed monomers for ALIX Bro1-V and ALIX V as expected (Fisher et al., 2007) (Lee et al., 2007) as well as dimeric forms with average molecular weights of 158 ± 3 kDa for ALIX Bro1-V ( Figure 1A ) and 76 ± 3 kDa for ALIX V ( Figure 1B ). The ratio of monomers to dimers 6 purified from E. c ol i was ~ 5:1 for ALIX Bro1-V and ~ 3:1 for ALIX V . Neither ALIX Bro1-V nor ALIX V monomers display a concentration dependent equilibrium with their respective dimers. Concentration of ALIX Bro1-V and ALIX V monomers up to 20 mg/ml did not produce dimers, nor did dilution of dimers produce monomers as j udged by gel filtration chromatography in agreement with analytical ultracentrifugation results (Fisher et al., 2007) . Thus no dimer to monomer exchange could be observed.
In order to understand the structural basis of ALIX dimerization, both ALIX Bro1-V monomers and dimers were analyzed by small angle X-ray scattering. The scattering intensity patterns corresponding to monomeric and dimeric ALIX Bro1-V are shown in of ~170 ǖ IRU WKH PRQRPHULF $/,; Bro1-V and ~300 ǖ IRU GLPHULF ALIX Bro1-V were found by the distance distribution function p(r) computed by a Fourier transformation of the scattering intensity ( Figure 2B ). This thus indicated that dimerization produced an elongated shaped ALIX Bro1-V . The shapes of the ALIX conformers were determined ab initio and reconstructed models of ALIX Bro1-V fit the corresponding experimental data ZLWK WKH GLVFUHSDQF\ Ȥ RI DQG . The ab initio modeling produced an elongated shape with dimensions of ~ 40 x 60 x 145 ǖ for monomeric ALIX Bro1-V ( Figure 2B , inset), which is largely consistent with the crystal structure of ALIX Bro1-V (Fisher et al., 2007) .
Comparison of the experimental scattering curve and the one calculated from the ALIX Bro1-V crystal structure revealed a discrepancy Ȥ RI Ab initio modeling of dimeric ALIX Bro1-V yielded a crescent-shaped structure with a distance of ~ 270 ǖ between the ends spanning the concave surface of the dimer ( Figure 2C ). (Fisher et al., 2007) (Lee et al., 2007) , suggesting that this region is occluded in dimeric ALIX ( Figure 3A ). The labeling method also revealed higher accessibilities to D 2 O labeling in the dimer as compared to the monomer ( Figure S1 ); this includes one region between the two arms of ALIX V (helices D11 and D18), several short helical segments within ALIX Bro1 (helices D4, D5, D8
and D10) and the long extended conformation spanning the concave surface of ALIX Bro1 connecting D10 and D11 ( Figures 3B and S1 ). The data thus indicate a dimerization interface within ALIX V and potential conformational flexibility within ALIX Bro1 .
Ge ne rati on of an e l ongate d "ope n" monome ri c ALI X V conf ormati on. In order to analyze the role of the ALIX V hinge region in dimerization, exposed residues within the segment 638-KMKQSNNE-645, that revealed differences in deuterium incorporation ( Figure 3A ) were changed to residues 638-EAAQSYKK-645 (ALIX Vmut1 ) and to residues 638-KMKQSYKK-645 (ALIX Vmut2 ). Size exclusion chromatography (SEC) analyses showed that ALIX Vmut1 eluted as a single peak at ~12 ml from a Superdex 200 column, a behavior which is different from the elution profile of ALIX V , which forms monomers and dimers (peaks at ~11.6 and ~13.5 ml) ( Figure 4A ). SEC of ALIX-V mut2 produced two new peaks eluting at ~11.2 and at 12.6 ml ( Figure 4A ). Applying MALLS, the single peak ALI X Bro1-V e xpre ssi on i n mammal i an ce l l s i nduce s di me ri z ati on. We used the split YFP complementation assay to test ALIX dimerization in cells (Michnick et al., 2007) .
Both N-terminal YFP and C-terminal YFP halves were fused to the C-terminus of ALIX Bro1-V and expressed in HEK293 cells. Fluorescence analyses by confocal microscopy revealed detection of YFP fused to ALIX Bro1-V only when both fusion proteins were co-expressed ( Figure 6A , right panel). This thus indicates that ALIX Bro1-V forms dimers when expressed in mammalian cells, which mainly localize to the cytoplasm.
Both ALI X V monome rs and di me rs i nte ract wi th a l ate domai n pe pti de . In order to determine whether dimeric ALIX might affect enveloped virus budding, isothermal calorimetry was performed to determine the interaction of ALIX V with a peptide derived from EIAV Gag p9. This revealed equilibrium dissociation constants (K D ) of 5 +/-0.3 ȝ0 for monomeric ALIX V , consistent with the reported interactions of ALIX monomers and retroviral late domains (Fisher et al., 2007; Lee et al., 2007; Zhai et al., 2008) and of 8 +/-1.2 ȝ0 IRU GLPHULF ALIX V . Thus dimeric ALIX constitutes a target for retroviral Gag.
ALI X di me ri z ati on i s i mportant f or HI V-1 buddi ng. We tested the effect of ALIX dimerization on HIV-1 budding since RFP-ALIX V-PRD expression has been shown to exert a dominant negative effect on HIV-1 particle release . Expression of and spiral structures are observed with dimeric ALIX Bro1-V spanning a distance of ~ 450Å, with a spacing of ~50 Å between rungs ( Figure 9I ). The cryo images also show mostly ladders as observed by negative staining although it cannot be excluded that some cross linking between ladders occurs ( Figure S3 ). The difference in spacing observed by negative staining and cryo EM might be either due to the fact that (i) binding of ALIX Bro1-V is sensitive to the heavy atom solution used for negative staining or due to the fact that (ii) ALIX Bro1-V , which is in contact with the carbon is embedded with heavy atom and visualized, a phenomenon observed previously (Gaillard et al., 2008) . Each Ce l l ul ar l ocal i z ati on of acti vate d CHM P4B and ALI X Bro1-V . To determine whether activated CHMP4B ǻ&B$/,; localizes to membranes and/or induces membrane remodeling (Hanson et al., 2008) in the absence of other ESCRT factors, CHMP4B ǻ&B$/,; was expressed with a C-terminal flag-tag in HEK293 cells. Immunostaining revealed that CHMP4B ǻ&B$/,; concentrates in inclusions that appear to be close to the plasma membrane ( Figure 6B ) similar to a previous report (Lin et al., 2005) ; upon co-expression with dimeric ALIX Bro1-V fused to the two YFP Venus halves most of ALIX Bro1-V is also recruited into CHMP4B ǻ&B$/,; positive inclusions ( Figure 6C ), thus indicating that dimeric ALIX targets ESCRT-III CHMP4 polymers in vivo.
Di scussi on
ALIX is a cellular adaptor protein that engages in a number of seemingly unrelated processes ranging from endosomal trafficking (Saksena et al., 2007) , apoptosis (Vito et al., 1999) (Missotten et al., 1999) , cytoskeleton reorganization (Cabezas et al., 2005 ) (Pan et al., 2006) , retrovirus budding (Usami et al. 2009 ) and cytokinesis (Carlton and Martin-Serrano, 2007) (Morita et al., 2007) . Thus ALIX underlies tight regulation that requires the C-terminal proline-rich region (PRD) harboring numerous protein-protein interacting motifs important for function and regulation of Alix (Odorizzi, 2006) . PRD keeps ALIX in an auto-inhibited conformation (Zhou et al., 2008b) (Zhou et al., 2008a ) (Lazert et al., 2008) ,which suggests that ALIX has to be activated. Our data indicate that activation of ALIX induces dimerization. Oligomerization and dimerization of ALIX was observed previously (Munshi et al., 2007) (Fisher et al., 2007) , and we confirm that the V-domain is sufficient for dimerization. It is, however, yet unclear which signal induces dimerization in vitro and in vivo. We show that both ALIX Bro1-V and ALIX V monomers and dimers are stable entities and do not exchange in vitro (Fisher et al., 2007) . ALIX Bro1-V contains a Bro1 domain (Kim et al., 2005 ) and a central V-shaped domain (Fisher et al., 2007) (Lee et al., 2007) . Bro1 interacts with ESCRT-III CHMP4 and the V-domain harbors the retroviral late domain binding site (Kim et al., 2005) (Zhai et al., 2008 )(McCullough et al., 2008 (Lee et al., 2007) . SAXS analyses of dimeric ALIX Bro1-V revealed an elongated ALIX Bro1-V structure that measures ~ twice the length of monomeric ALIX Bro1-V . Interestingly, the shape of dimeric ALIX Bro1-V resembles that of BAR domains such as amphipysin (Peter et al., 2004) and endophilin (Weissenhorn, 2005) . Although we observe membrane interaction of ALIX Bro1-V in vitro (data not shown) no specific membrane remodeling effect could be assigned. Thus, the architecture might be preferentially used to bridge two effector molecules.
Since no concentration dependent equilibrium between monomers and dimers could be detected (Fisher et al., 2007) , dimer formation must include specific conformational changes. Hydrogen/deuterium exchange experiments coupled to mass spectrometry peptide mapping revealed several sites of conformational flexibility, notably not only within the V-dimerization domain but also within the Bro1 domain.
Such conformational flexibility is consistent with the structure of ALIX Bro1-V , which shows that Bro1 and V are connected via a short linker as well as some degree of inserm-00405383, version 1 -25 Jan 2010 flexibility between the two arms of the V domain (Fisher et al., 2007) . The mutagenesis studies suggest that the two arms of ALIX V are connected via a hinge region, which is stabilized in the crystal structure by a salt bridge between K640 and E650, that also hydrogen bonds to N400 (Lee et al., 2007) (Fisher et al., 2007) . A set of mutations within this region including K640 destabilized the monomer and in addition prevented protein binding which might position the complex within the correct network of interactions required to trigger down stream effects. Thus ALIX Bro1-Vmut1 that no longer dimerizes has no effect on the budding process. The dominant negative effect may further depend on the interaction with Gag, since dimeric ALIX V interacts with a EIAV late domain peptide with a similar K d as reported for monomeric ALIX V (Munshi et al., 2007) (Fisher et al., 2007) .
Several lines of evidence suggest that ALIX functions directly on membranes.
Firstly, ALIX localizes to the plasma and endosomal membranes (Welsch et al., 2006) . Secondly, it plays a role in the formation of internal endosomal membranes in conj unction with lysobiphosphatidic acid (LBPA) (Matsuo et al., 2004) . Thirdly, expression of ALIX V-PRD was shown to induce cytoplasmic vacuolization into tubulovesicular structures that co-localize with ALIX (Chatellard-Causse et al., 2002); this effect might be also due to the formation of mutant-wild type ALIX heterodimers that lack important binding sites. Fourthly, it is recruited by interaction with ESCRT-III CHMP4, which acts at membranes (Katoh et al., 2003 )(von Schwedler et al., 2003 . ESCRT-III proteins CHMP2A and CHMP3 have been shown to assemble into heteromeric helical polymers that may catalyze late budding steps such as abscission (Lata et al., 2008b) . Similarly, ESCRT-III CHMP4 expression in mammalian cells was shown to form circular filaments (Hanson et al., 2008) (Hanson et al., 2008 ) that drive early steps in HIV-1 assembly and budding (Carlson et al., 2008) .
Both ALIX and CHMP4B are present at the midbody (Carlton and MartinSerrano, 2007) (Morita et al., 2007) and CHMP4-ALIX-CEP55 interactions are essential for midbody formation (Carlton et al., 2008) . Since dimeric ALIX Bro1-V bridges preferentially two CHMP4B filaments or spirals in vitro, ALIX could support CHMP4 polymer positioning on membranes during viral budding as well as at the midbody supported by CEP55 (Carlton et al., 2008) (Morita et al., 2007) . ALIX polymerizes itself (Carlton et al., 2008) whereas dimeric ALIX might constitute the the building block for CHMP4 induced polymerization at budding sites. Because ALIX Bro1-V lacks the multimerization site (Carlton et al., 2008) , we do not observe ALIX polymers in vitro.
Polymerization of ALIX is further supported by the stochiometry of ESCRT-III.
ESCRT-III contains multiple copies of CHMP4 (Teis et al., 2008) (Saksena et al., 2009) supporting CHMP4 polymerization which in turn provides multiple binding sites for ALIX polymerization.
The formation and physiological role of ALIX dimers was further proven by using a YFP complementation assay (Michnick et al., 2007) . Dimeric ALIX Bro1-V -YFP inserm-00405383, version 1 -25 Jan 2010 is mostly found in the cytosol, indicating that dimerization is not sufficient for membrane targeting. When it is expressed together with CHMP4B ǻ&-ALIX both structures co-localize in large inclusions, demonstrating that polymeric CHMP4B recruits dimeric ALIX in vivo. Thus our data suggest that recruitment of activated ESCRT-III CHMP4B entails the function of dimeric ALIX Bro1-V . This might help to position ESCRT-III at sites of membrane remodeling by providing access to the cytoskeleton (Cabezas et al., 2005) (Pan et al., 2006) .
Expe ri me ntal proce dure s Prote i n e xpre ssi on and puri f i cati on
Cloning, expression, purification and SEC characterization including MALLS of ALIX and CHMP4B constructs is described in the supporting online material (SOM).
Smal l Angl e Scatte ri ng Data Col l e cti on and Anal ysi s
The synchrotron radiation X-ray scattering data were collected on the X33 SAXS beam line (DESY and EMBL, Hamburg) (Koch and Bordas, 1983; Roessle et al., 2007) and at the ESRF beam line ID02 (Grenoble). A MAR345 image plate with online readout (MarResearch, Germany) was used at a sample -detector distance of 2.4 m covering the range of momentum transfer 0.1 < s < 4.5 nm 
Hydroge n/ de ute ri um ( H/ D) e xchange mass spe ctrome try ( M S)
Deuterium labeling of monomeric and dimeric ALIX Bro1-V was carried out by 20-fold dilution of the protein samples in deuterated buffer (5mM Hepes, 100mM NaCl in D 2 O, pD 7.6) followed by incubation at 4º C for different time intervals (from 10 s to 30 min).
The reaction was quenched by lowering the pD to 2.1 with 0.1 M HCl solution. Pepsin (Sigma-Aldrich) digestion was performed at 4º C and pH 2.5 for 2 min in 0.1 M HCl and a protein:protease ratio of 1:1 (w/w). Further details are reported in SOM.
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El e ctron mi croscopy CHMP4B ǻ&-Alix and ALIX Bro1-V were purified by sucrose gradient centrifugation (Lata et al., 2008b) and samples present in the bottom fractions were analyzed by electron microscopy using negative staining with uranyl acetate or sodium silicotungstate (pH 7.0) (Lata et al., 2008b) . For cryo electron microscopy CHMP4B ǻ&-Alix alone or in complex with ALIX Bro1-V the sucrose was removed and ȝO sample were loaded onto a Quantifoil R2/1 holey grid (Quantifoil Micro Tools GmbH, Germany). The grids were treated and observed using a JEOL 2010 FEG electron microscope (Schoehn et al., 2008) . 
Siz e exclusion chromatography and multi-angle laser scattering
Size exclusion chromatography was performed with a Shodex Protein KW-804 HPLC column (300 mm x 8.0 mm). The column was equilibrated in buffer E (20 mM Tris pH 7.5, 150 mM NaCl) and the runs were perform at 20 °C with a flow rate of 0.8 ml/ min.
Stokes' radii were determined by calibrating the column with globular proteins of known Stokes' radius. On-line detection was performed by multi-angle laser light scattering (MALLS) using a DAWN-EOS detector (Wyatt Technology Corp., Santa Barbara, CA) equipped with a laser emitting at 690 nm and by refractive index measurement using a RI2000 detector (Schambeck SFD). Light scattering intensities were measured at different angles relative to the incident beam, and analysis of the data was performed with the ASTRA software (Wyatt Technology Corp., Santa Barbara, CA). Weightaveraged (Mw) molecular weights were obtained from the molecular weight distribution across the elution peak as described (Lata et al., 2008) . The virus release assays were performed as described . Briefly, 293T cells (1.2 x 10 6 ) were cotransfected with 1. ȝJ RI +;%+ ZKLFK HQFRGHV :7 +,9-1, Protein samples were prepared in 20 mM Hepes pH 8.0, 100 mM NaCl. Repetitive measurements of 180 sec at 15 °C of the same protein solution were performed in order to check for radiation damage. The data were normalized to the intensity of the incident beam; the scattering of the buffer was subtracted and the difference curves were scaled for concentration. Data processing was performed using the program package PRIMUS (Konarev et al., 2003) . The forward scattering I( 0) and the radius of gyration Rg were evaluated using the Guinier approximation (Guinier, 1939) assuming that at very small angles (s < 1. 3/ R g ) the intensity is represented by I( s) = I( 0) e x p( -( sR g ) 2 / 3). These parameters were also computed from the entire scattering patterns using the indirect transform package GNOM (Svergun, 1992) , which also provide the distance distribution function p( r) of the particle ( Low-resolution models of monomeric ALIX Bro1-V , dimeric ALIX Bro1-V and monomeric ALIX Vmut1 were built by the program DAMMIN (Svergun, 1999) where N is the number of experimental points, c a scaling factor and I calc (s j ) and ı(s j ) are the calculated intensity and the experimental error at the momentum transfer s j , respectively. Ten independent DAMMIN bead models for monomeric and dimeric ALIX Bro1-V and for ALIX Vmut1 were calculated. Final models of these proteins were obtained by superposition of the ten independent shape reconstructions for each protein by using the program packages DAMAVER and SUBCOMP (Kozin and Svergun, 2001) . For dimeric ALIX Bro1-V ab i ni t i oshape models were calculated either without symmetry constrains or assuming a 2-fold symmetry axis.
For the symmetric models, ten DAMMIN models were obtained, superimposed and averaged. The overall envelope, especially the crescent-shape of dimeric ALIX Bro1-V was the same for both unconstrained and constrained models.
